{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T03:35:44Z","timestamp":1794800144163,"version":"4.9.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG054223"],"award-info":[{"award-number":["RF1 AG054223"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG056061"],"award-info":[{"award-number":["RF1 AG056061"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS114130-01A1"],"award-info":[{"award-number":["R01 NS114130-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG071587"],"award-info":[{"award-number":["RF1 AG071587"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 NS099474"],"award-info":[{"award-number":["K08 NS099474"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG063175"],"award-info":[{"award-number":["R01 AG063175"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG063175"],"award-info":[{"award-number":["R01 AG063175"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH106575"],"award-info":[{"award-number":["R01 MH106575"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 R01NS115994"],"award-info":[{"award-number":["R01 R01NS115994"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CAREER 1944053"],"award-info":[{"award-number":["CAREER 1944053"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The <jats:italic>BIN1<\/jats:italic> locus contains the second-most significant genetic risk factor for late-onset Alzheimer\u2019s disease. <jats:italic>BIN1<\/jats:italic> undergoes alternate splicing to generate tissue- and cell-type-specific BIN1 isoforms, which regulate membrane dynamics in a range of crucial cellular processes. Whilst the expression of BIN1 in the brain has been characterized in neurons and oligodendrocytes in detail, information regarding microglial BIN1 expression is mainly limited to large-scale transcriptomic and proteomic data. Notably, BIN1 protein expression and its functional roles in microglia, a cell type most relevant to Alzheimer\u2019s disease, have not been examined in depth.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Microglial BIN1 expression was analyzed by immunostaining mouse and human brain, as well as by immunoblot and RT-PCR assays of isolated microglia or human iPSC-derived microglial cells. <jats:italic>Bin1<\/jats:italic> expression was ablated by siRNA knockdown in primary microglial cultures in vitro and Cre-lox mediated conditional deletion in adult mouse brain microglia in vivo. Regulation of neuroinflammatory microglial signatures by BIN1 in vitro and in vivo was characterized using NanoString gene panels and flow cytometry methods. The transcriptome data was explored by in silico pathway analysis and validated by complementary molecular approaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here, we characterized microglial BIN1 expression in vitro and in vivo and ascertained microglia expressed BIN1 isoforms. By silencing <jats:italic>Bin1<\/jats:italic> expression in primary microglial cultures, we demonstrate that BIN1 regulates the activation of proinflammatory and disease-associated responses in microglia as measured by gene expression and cytokine production. Our transcriptomic profiling revealed key homeostatic and lipopolysaccharide (LPS)-induced inflammatory response pathways, as well as transcription factors PU.1 and IRF1 that are regulated by BIN1. Microglia-specific <jats:italic>Bin1<\/jats:italic> conditional knockout in vivo revealed novel roles of BIN1 in regulating the expression of disease-associated genes while counteracting CX3CR1 signaling. The consensus from in vitro and in vivo findings showed that loss of <jats:italic>Bin1<\/jats:italic> impaired the ability of microglia to mount type 1 interferon responses to proinflammatory challenge, particularly the upregulation of a critical type 1 immune response gene, <jats:italic>Ifitm3<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our convergent findings provide novel insights into microglial BIN1 function and demonstrate an essential role of microglial BIN1 in regulating brain inflammatory response and microglial phenotypic changes. Moreover, for the first time, our study shows a regulatory relationship between <jats:italic>Bin1<\/jats:italic> and <jats:italic>Ifitm3<\/jats:italic>, two Alzheimer\u2019s disease-related genes in microglia. The requirement for BIN1 to regulate <jats:italic>Ifitm3<\/jats:italic> upregulation during inflammation has important implications for inflammatory responses during the pathogenesis and progression of many neurodegenerative diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13024-022-00535-x","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:21:02Z","timestamp":1651922462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia"],"prefix":"10.1186","volume":"17","author":[{"given":"Ari","family":"Sudwarts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Ramesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moorthi","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bitarafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beaulieu-Abdelahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Szekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi B.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jubao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-6780","authenticated-orcid":false,"given":"Gopal","family":"Thinakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-1500","authenticated-orcid":false,"given":"Srikant","family":"Rangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"535_CR1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. Jama. 2010;303:1832\u201340.","journal-title":"Jama"},{"key":"535_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011;43:436\u201341.","journal-title":"Nat Genet"},{"key":"535_CR3","first-page":"320","volume":"68","author":"JH Lee","year":"2011","unstructured":"Lee JH, Cheng R, Barral S, Reitz C, Medrano M, Lantigua R, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol. 2011;68:320\u20138.","journal-title":"Arch Neurol"},{"key":"535_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00109-014-1138-1","volume":"92","author":"I Prokic","year":"2014","unstructured":"Prokic I, Cowling BS, Laporte J. Amphiphysin 2 (BIN1) in physiology and diseases. J Mol Med. 2014;92:453\u201363.","journal-title":"J Mol Med"},{"issue":"3520-3535","key":"535_CR5","volume":"30","author":"P De Rossi","year":"2020","unstructured":"De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, et al. Neuronal BIN1 regulates presynaptic neurotransmitter release and memory consolidation. Cell Rep. 2020;30(3520-3535):e3527.","journal-title":"Cell Rep"},{"key":"535_CR6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s001289900812","volume":"61","author":"MJ Zabik","year":"1998","unstructured":"Zabik MJ, Polin D, Underwood M, Wiggers P, Zabik ME. Tissue residues in male chickens fed a 50 ng\/kg dietary concentration of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Bull Environ Contam Toxicol. 1998;61:664\u20138.","journal-title":"Bull Environ Contam Toxicol"},{"key":"535_CR7","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1074\/jbc.RA118.006379","volume":"294","author":"RJ Andrew","year":"2019","unstructured":"Andrew RJ, De Rossi P, Nguyen P, Kowalski HR, Recupero AJ, Guerbette T, et al. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model. J Biol Chem. 2019;294:4477\u201387.","journal-title":"J Biol Chem"},{"key":"535_CR8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013;18:1225\u201334.","journal-title":"Mol Psychiatry"},{"key":"535_CR9","doi-asserted-by":"crossref","unstructured":"Voskobiynyk Y, Roth JR, Cochran JN, Rush T, Carullo NV, Mesina JS, et al. Alzheimer's disease risk gene BIN1 induces tau-dependent network hyperexcitability. Elife. 2020;9:e57354.","DOI":"10.7554\/eLife.57354"},{"key":"535_CR10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","volume":"17","author":"S Calafate","year":"2016","unstructured":"Calafate S, Flavin W, Verstreken P, Moechars D. Loss of Bin1 promotes the propagation of tau pathology. Cell Rep. 2016;17:931\u201340.","journal-title":"Cell Rep"},{"key":"535_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-016-0124-1","volume":"11","author":"P De Rossi","year":"2016","unstructured":"De Rossi P, Buggia-Prevot V, Clayton BL, Vasquez JB, van Sanford C, Andrew RJ, et al. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Mol Neurodegener. 2016;11:59.","journal-title":"Mol Neurodegener"},{"key":"535_CR12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13024-017-0219-3","volume":"12","author":"AT McKenzie","year":"2017","unstructured":"McKenzie AT, Moyon S, Wang M, Katsyv I, Song WM, Zhou X, et al. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease. Mol Neurodegener. 2017;12:82.","journal-title":"Mol Neurodegener"},{"key":"535_CR13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-132450","volume":"42","author":"CJ Holler","year":"2014","unstructured":"Holler CJ, Davis PR, Beckett TL, Platt TL, Webb RL, Head E, et al. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology. J Alzheimers Dis. 2014;42:1221\u20137.","journal-title":"J Alzheimers Dis"},{"key":"535_CR14","doi-asserted-by":"crossref","unstructured":"De Rossi P, Buggia-Prevot V, Andrew RJ, Krause SV, Woo E, Nelson PT, et al. BIN1 localization is distinct from tau tangles in Alzheimer's disease. Matters (Zur). 2017;0.19185\/matters.201611000018.","DOI":"10.19185\/matters.201611000018"},{"key":"535_CR15","doi-asserted-by":"crossref","unstructured":"Adams SL, Tilton K, Kozubek JA, Seshadri S, Delalle I. Subcellular changes in bridging integrator 1 protein expression in the cerebral cortex during the progression of Alzheimer disease pathology. J Neuropathol Exp Neurol. 2016;75:779-790.","DOI":"10.1093\/jnen\/nlw056"},{"key":"535_CR16","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929\u201347.","journal-title":"J Neurosci"},{"key":"535_CR17","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","volume":"113","author":"ML Bennett","year":"2016","unstructured":"Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113:E1738\u201346.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"535_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37\u201353.","journal-title":"Neuron"},{"key":"535_CR19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343.","journal-title":"Nat Neurosci"},{"key":"535_CR20","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/nn.4160","volume":"18","author":"K Sharma","year":"2015","unstructured":"Sharma K, Schmitt S, Bergner CG, Tyanova S, Kannaiyan N, Manrique-Hoyos N, et al. Cell type- and brain region-resolved mouse brain proteome. Nat Neurosci. 2015;18:1819\u201331.","journal-title":"Nat Neurosci"},{"key":"535_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Mol Neurodegener. 2018;13:24.","journal-title":"Mol Neurodegener"},{"issue":"566-581","key":"535_CR22","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(566-581):e569.","journal-title":"Immunity"},{"issue":"60-72","key":"535_CR23","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, et al. A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer's disease. Cell Syst. 2017;4(60-72):e64.","journal-title":"Cell Syst"},{"key":"535_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.immuni.2016.02.013","volume":"44","author":"A Crotti","year":"2016","unstructured":"Crotti A, Ransohoff RM. Microglial physiology and pathophysiology: insights from genome-wide transcriptional profiling. Immunity. 2016;44:505\u201315.","journal-title":"Immunity"},{"issue":"1276-1290","key":"535_CR25","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer's disease. Cell. 2017;169(1276-1290):e1217.","journal-title":"Cell"},{"key":"535_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-018-0266-4","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Dammer EB, Raza SA, Gao T, Xiao H, Betarbet R, et al. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins. Mol Neurodegener. 2018;13:34.","journal-title":"Mol Neurodegener"},{"key":"535_CR27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)65423-5","volume":"154","author":"M Stalder","year":"1999","unstructured":"Stalder M, Phinney A, Probst A, Sommer B, Staufenbiel M, Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol. 1999;154:1673\u201384.","journal-title":"Am J Pathol"},{"key":"535_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9440(10)63945-4","volume":"158","author":"KD Bornemann","year":"2001","unstructured":"Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, et al. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol. 2001;158:63\u201373.","journal-title":"Am J Pathol"},{"key":"535_CR29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer's disease. J Cell Biol. 2018;217:459\u201372.","journal-title":"J Cell Biol"},{"key":"535_CR30","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer's disease. J Clin Invest. 2017;127:3240\u20139.","journal-title":"J Clin Invest"},{"key":"535_CR31","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/glia.23678","volume":"67","author":"T Gao","year":"2019","unstructured":"Gao T, Jernigan J, Raza SA, Dammer EB, Xiao H, Seyfried NT, et al. Transcriptional regulation of homeostatic and disease-associated-microglial genes by IRF1, LXRbeta, and CEBPalpha. Glia. 2019;67:1958\u201375.","journal-title":"Glia"},{"key":"535_CR32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-018-0277-1","volume":"13","author":"J Rustenhoven","year":"2018","unstructured":"Rustenhoven J, Smith AM, Smyth LC, Jansson D, Scotter EL, Swanson MEV, et al. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia. Mol Neurodegener. 2018;13:44.","journal-title":"Mol Neurodegener"},{"key":"535_CR33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","volume":"586","author":"JY Hur","year":"2020","unstructured":"Hur JY, Frost GR, Wu X, Crump C, Pan SJ, Wong E, et al. The innate immunity protein IFITM3 modulates gamma-secretase in Alzheimer's disease. Nature. 2020;586:735\u201340.","journal-title":"Nature"},{"key":"535_CR34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/1753425912443392","volume":"18","author":"YS Wee","year":"2012","unstructured":"Wee YS, Roundy KM, Weis JJ, Weis JH. Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun. 2012;18:834\u201345.","journal-title":"Innate Immun"},{"key":"535_CR35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.celrep.2015.09.048","volume":"13","author":"S Ranjbar","year":"2015","unstructured":"Ranjbar S, Haridas V, Jasenosky LD, Falvo JV, Goldfeld AE. A role for IFITM proteins in restriction of mycobacterium tuberculosis infection. Cell Rep. 2015;13:874\u201383.","journal-title":"Cell Rep"},{"key":"535_CR36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1172\/JCI84889","volume":"127","author":"MA Stacey","year":"2017","unstructured":"Stacey MA, Clare S, Clement M, Marsden M, Abdul-Karim J, Kane L, et al. The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis. J Clin Invest. 2017;127:1463\u201374.","journal-title":"J Clin Invest"},{"key":"535_CR37","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.00655-16","volume":"90","author":"S Poddar","year":"2016","unstructured":"Poddar S, Hyde JL, Gorman MJ, Farzan M, Diamond MS. The interferon-stimulated gene IFITM3 restricts infection and pathogenesis of Arthritogenic and encephalitic Alphaviruses. J Virol. 2016;90:8780\u201394.","journal-title":"J Virol"},{"key":"535_CR38","volume":"14","author":"GD Vavougios","year":"2021","unstructured":"Vavougios GD, Nday C, Pelidou SH, Gourgoulianis KI, Stamoulis G, Doskas T, et al. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease. Brain Behav Immun Health. 2021;14:100243.","journal-title":"Brain Behav Immun Health"},{"key":"535_CR39","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1158\/0008-5472.CAN-07-1100","volume":"67","author":"MY Chang","year":"2007","unstructured":"Chang MY, Boulden J, Katz JB, Wang L, Meyer TJ, Soler AP, et al. Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer. Cancer Res. 2007;67:7605\u201312.","journal-title":"Cancer Res"},{"key":"535_CR40","doi-asserted-by":"crossref","first-page":"15554","DOI":"10.1038\/ncomms15554","volume":"8","author":"A Shihavuddin","year":"2017","unstructured":"Shihavuddin A, Basu S, Rexhepaj E, Delestro F, Menezes N, Sigoillot SM, et al. Smooth 2D manifold extraction from 3D image stack. Nat Commun. 2017;8:15554.","journal-title":"Nat Commun"},{"key":"535_CR41","doi-asserted-by":"crossref","unstructured":"Ramesha S, Rayaprolu S, Rangaraju S. Flow Cytometry approach to characterize phagocytic properties of acutely-isolated adult microglia and brain macrophages in vitro. J Vis Exp. 2020;160:e61467.","DOI":"10.3791\/61467"},{"key":"535_CR42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jneumeth.2010.11.001","volume":"194","author":"R Gordon","year":"2011","unstructured":"Gordon R, Hogan CE, Neal ML, Anantharam V, Kanthasamy AG, Kanthasamy A. A simple magnetic separation method for high-yield isolation of pure primary microglia. J Neurosci Methods. 2011;194:287\u201396.","journal-title":"J Neurosci Methods"},{"key":"535_CR43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneumeth.2008.08.016","volume":"175","author":"R Marek","year":"2008","unstructured":"Marek R, Caruso M, Rostami A, Grinspan JB, Das Sarma J. Magnetic cell sorting: a fast and effective method of concurrent isolation of high purity viable astrocytes and microglia from neonatal mouse brain tissue. J Neurosci Methods. 2008;175:108\u201318.","journal-title":"J Neurosci Methods"},{"key":"535_CR44","first-page":"85","volume":"5","author":"RR Butler Iii","year":"2020","unstructured":"Butler Iii RR, Kozlova A, Zhang H, Zhang S, Streit M, Sanders AR, et al. The genetic relevance of human induced pluripotent stem cell-derived microglia to Alzheimer's disease and major neuropsychiatric disorders. Mol Neuropsychiatry. 2020;5:85\u201396.","journal-title":"Mol Neuropsychiatry"},{"key":"535_CR45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.aay3983","volume":"369","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhang H, Zhou Y, Qiao M, Zhao S, Kozlova A, et al. Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants. Science. 2020;369:561\u20135.","journal-title":"Science"},{"key":"535_CR46","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.stemcr.2018.03.003","volume":"10","author":"PW Brownjohn","year":"2018","unstructured":"Brownjohn PW, Smith J, Solanki R, Lohmann E, Houlden H, Hardy J, et al. Functional studies of missense TREM2 mutations in human stem cell-derived microglia. Stem Cell Reports. 2018;10:1294\u2013307.","journal-title":"Stem Cell Reports"},{"key":"535_CR47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-017-0906-6","volume":"14","author":"S Rangaraju","year":"2017","unstructured":"Rangaraju S, Raza SA, Pennati A, Deng Q, Dammer EB, Duong D, et al. A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation. J Neuroinflammation. 2017;14:128.","journal-title":"J Neuroinflammation"},{"key":"535_CR48","doi-asserted-by":"crossref","unstructured":"Ramesha S, Rayaprolu S, Bowen CA, Giver CR, Bitarafan S, Nguyen HM, et al. Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's disease. Proc Natl Acad Sci U S A. 2021;118:e2013545118.","DOI":"10.1073\/pnas.2013545118"},{"key":"535_CR49","doi-asserted-by":"crossref","first-page":"W755","DOI":"10.1093\/nar\/gkq405","volume":"38","author":"D Emig","year":"2010","unstructured":"Emig D, Salomonis N, Baumbach J, Lengauer T, Conklin BR, Albrecht M. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 2010;38:W755\u201362.","journal-title":"Nucleic Acids Res"},{"key":"535_CR50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2018.00405","volume":"9","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Raza SA, Li NX, Betarbet R, Dammer EB, Duong D, et al. Differential phagocytic properties of CD45(low) microglia and CD45(high) brain mononuclear phagocytes-activation and age-related effects. Front Immunol. 2018;9:405.","journal-title":"Front Immunol"},{"key":"535_CR51","volume-title":"Book FracLac for ImageJ (Editor ed.^eds.). City","author":"A K","year":"1999","unstructured":"A K. FracLac for ImageJ. In:  Book FracLac for ImageJ (Editor ed.^eds.). City; 1999-2013."},{"key":"535_CR52","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng2086","volume":"39","author":"AS Nicot","year":"2007","unstructured":"Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, Iwarsson E, et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet. 2007;39:1134\u20139.","journal-title":"Nat Genet"},{"key":"535_CR53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry. 2010;68:930\u201341.","journal-title":"Biol Psychiatry"},{"key":"535_CR54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","volume":"76","author":"R Taipa","year":"2019","unstructured":"Taipa R, das Neves SP, Sousa AL, Fernandes J, Pinto C, Correia AP, et al. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline. Neurobiol Aging. 2019;76:125\u201332.","journal-title":"Neurobiol Aging"},{"key":"535_CR55","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/jnr.24829","volume":"99","author":"MJ Chen","year":"2021","unstructured":"Chen MJ, Ramesha S, Weinstock LD, Gao T, Ping L, Xiao H, et al. Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer's disease. J Neurosci Res. 2021;99:1704\u201321.","journal-title":"J Neurosci Res"},{"key":"535_CR56","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","volume":"155","author":"CN Parkhurst","year":"2013","unstructured":"Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596\u2013609.","journal-title":"Cell"},{"key":"535_CR57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fncel.2018.00215","volume":"12","author":"S Lively","year":"2018","unstructured":"Lively S, Schlichter LC. Microglia responses to pro-inflammatory stimuli (LPS, IFNgamma+TNFalpha) and reprogramming by resolving cytokines (IL-4, IL-10). Front Cell Neurosci. 2018;12:215.","journal-title":"Front Cell Neurosci"},{"key":"535_CR58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-019-1644-8","volume":"17","author":"X Ye","year":"2020","unstructured":"Ye X, Zhu M, Che X, Wang H, Liang XJ, Wu C, et al. Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation. J Neuroinflammation. 2020;17:18.","journal-title":"J Neuroinflammation"},{"key":"535_CR59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2020.00430","volume":"11","author":"A Benmamar-Badel","year":"2020","unstructured":"Benmamar-Badel A, Owens T, Wlodarczyk A. Protective microglial subset in development, aging, and disease: lessons from Transcriptomic studies. Front Immunol. 2020;11:430.","journal-title":"Front Immunol"},{"key":"535_CR60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556:332\u20138.","journal-title":"Nature"},{"key":"535_CR61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","volume":"9","author":"AE Cardona","year":"2006","unstructured":"Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9:917\u201324.","journal-title":"Nat Neurosci"},{"key":"535_CR62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","volume":"68","author":"KD Coon","year":"2007","unstructured":"Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68:613\u20138.","journal-title":"J Clin Psychiatry"},{"key":"535_CR63","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","volume":"177","author":"S Lee","year":"2010","unstructured":"Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, et al. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol. 2010;177:2549\u201362.","journal-title":"Am J Pathol"},{"key":"535_CR64","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1523\/JNEUROSCI.4822-05.2006","volume":"26","author":"AM Floden","year":"2006","unstructured":"Floden AM, Combs CK. Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J Neurosci. 2006;26:4644\u20138.","journal-title":"J Neurosci"},{"key":"535_CR65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-020-00387-3","volume":"15","author":"M Taga","year":"2020","unstructured":"Taga M, Petyuk VA, White C, Marsh G, Ma Y, Klein HU, et al. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology. Mol Neurodegener. 2020;15:44.","journal-title":"Mol Neurodegener"},{"key":"535_CR66","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1071362","volume":"297","author":"E Lee","year":"2002","unstructured":"Lee E, Marcucci M, Daniell L, Pypaert M, Weisz OA, Ochoa GC, et al. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science. 2002;297:1193\u20136.","journal-title":"Science"},{"key":"535_CR67","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science. 2019;366:1134\u20139.","journal-title":"Science"},{"key":"535_CR68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41588-021-00875-2","volume":"53","author":"AMH Young","year":"2021","unstructured":"Young AMH, Kumasaka N, Calvert F, Hammond TR, Knights A, Panousis N, et al. A map of transcriptional heterogeneity and regulatory variation in human microglia. Nat Genet. 2021;53:861\u20138.","journal-title":"Nat Genet"},{"key":"535_CR69","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1046\/j.1471-4159.1998.70062369.x","volume":"70","author":"AR Ramjaun","year":"1998","unstructured":"Ramjaun AR, McPherson PS. Multiple amphiphysin II splice variants display differential clathrin binding: identification of two distinct clathrin-binding sites. J Neurochem. 1998;70:2369\u201376.","journal-title":"J Neurochem"},{"key":"535_CR70","doi-asserted-by":"crossref","first-page":"16700","DOI":"10.1074\/jbc.272.26.16700","volume":"272","author":"AR Ramjaun","year":"1997","unstructured":"Ramjaun AR, Micheva KD, Bouchelet I, McPherson PS. Identification and characterization of a nerve terminal-enriched amphiphysin isoform. J Biol Chem. 1997;272:16700\u20136.","journal-title":"J Biol Chem"},{"key":"535_CR71","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/MCB.23.12.4295-4306.2003","volume":"23","author":"AJ Muller","year":"2003","unstructured":"Muller AJ, Baker JF, DuHadaway JB, Ge K, Farmer G, Donover PS, et al. Targeted disruption of the murine Bin1\/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. Mol Cell Biol. 2003;23:4295\u2013306.","journal-title":"Mol Cell Biol"},{"key":"535_CR72","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ncb1986","volume":"11","author":"S Pant","year":"2009","unstructured":"Pant S, Sharma M, Patel K, Caplan S, Carr CM, Grant BD. AMPH-1\/Amphiphysin\/Bin1 functions with RME-1\/Ehd1 in endocytic recycling. Nat Cell Biol. 2009;11:1399\u2013410.","journal-title":"Nat Cell Biol"},{"key":"535_CR73","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.1073\/pnas.96.17.9689","volume":"96","author":"K Ge","year":"1999","unstructured":"Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, Prendergast GC. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci U S A. 1999;96:9689\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"535_CR74","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1074\/jbc.RA118.005699","volume":"294","author":"WP Folk","year":"2019","unstructured":"Folk WP, Kumari A, Iwasaki T, Pyndiah S, Johnson JC, Cassimere EK, et al. Loss of the tumor suppressor BIN1 enables ATM Ser\/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin. J Biol Chem. 2019;294:5700\u201319.","journal-title":"J Biol Chem"},{"key":"535_CR75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jmb.2005.05.046","volume":"351","author":"A Pineda-Lucena","year":"2005","unstructured":"Pineda-Lucena A, Ho CS, Mao DY, Sheng Y, Laister RC, Muhandiram R, et al. A structure-based model of the c-Myc\/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. J Mol Biol. 2005;351:182\u201394.","journal-title":"J Mol Biol"},{"key":"535_CR76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ng0996-69","volume":"14","author":"D Sakamuro","year":"1996","unstructured":"Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet. 1996;14:69\u201377.","journal-title":"Nat Genet"},{"key":"535_CR77","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/glia.22486","volume":"61","author":"AM Smith","year":"2013","unstructured":"Smith AM, Gibbons HM, Oldfield RL, Bergin PM, Mee EW, Faull RL, et al. The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia. 2013;61:929\u201342.","journal-title":"Glia"},{"key":"535_CR78","doi-asserted-by":"crossref","first-page":"105217","DOI":"10.1016\/j.nbd.2020.105217","volume":"148","author":"AA Pimenova","year":"2021","unstructured":"Pimenova AA, Herbinet M, Gupta I, Machlovi SI, Bowles KR, Marcora E, et al. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response. Neurobiol Dis. 2021;148:105217.","journal-title":"Neurobiol Dis"},{"key":"535_CR79","doi-asserted-by":"crossref","first-page":"107530","DOI":"10.1016\/j.celrep.2020.107530","volume":"31","author":"SF Lau","year":"2020","unstructured":"Lau SF, Chen C, Fu WY, Qu JY, Cheung TH, Fu AKY, et al. IL-33-PU.1 Transcriptome reprogramming drives functional state transition and clearance activity of microglia in Alzheimer's disease. Cell Rep. 2020;31:107530.","journal-title":"Cell Rep"},{"key":"535_CR80","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/glia.22770","volume":"63","author":"T Tanaka","year":"2015","unstructured":"Tanaka T, Murakami K, Bando Y, Yoshida S. Interferon regulatory factor 7 participates in the M1-like microglial polarization switch. Glia. 2015;63:595\u2013610.","journal-title":"Glia"},{"key":"535_CR81","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.15252\/embj.201489293","volume":"33","author":"M Cohen","year":"2014","unstructured":"Cohen M, Matcovitch O, David E, Barnett-Itzhaki Z, Keren-Shaul H, Blecher-Gonen R, et al. Chronic exposure to TGFbeta1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. EMBO J. 2014;33:2906\u201321.","journal-title":"EMBO J"},{"key":"535_CR82","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nn.4587","volume":"20","author":"KL Huang","year":"2017","unstructured":"Huang KL, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SC, et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease. Nat Neurosci. 2017;20:1052\u201361.","journal-title":"Nat Neurosci"},{"key":"535_CR83","doi-asserted-by":"crossref","unstructured":"Gyoneva S, Hosur R, Gosselin D, Zhang B, Ouyang Z, Cotleur AC, et al. Cx3cr1-deficient microglia exhibit a premature aging transcriptome. Life Sci Alliance. 2019;2:e201900453.","DOI":"10.26508\/lsa.201900453"},{"key":"535_CR84","volume":"11","author":"Z Fan","year":"2020","unstructured":"Fan Z, Zhao S, Zhu Y, Li Z, Liu Z, Yan Y, et al. Interferon regulatory factor 5 mediates lipopolysaccharide-induced Neuroinflammation. Front Immunol. 2020;11:600479.","journal-title":"Front Immunol"},{"key":"535_CR85","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1038\/ncomms4771","volume":"5","author":"T Masuda","year":"2014","unstructured":"Masuda T, Iwamoto S, Yoshinaga R, Tozaki-Saitoh H, Nishiyama A, Mak TW, et al. Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain. Nat Commun. 2014;5:3771.","journal-title":"Nat Commun"},{"key":"535_CR86","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/ejn.13257","volume":"43","author":"L Gong","year":"2016","unstructured":"Gong L, Wang H, Sun X, Liu C, Duan C, Cai R, et al. Toll-interleukin 1 receptor domain-containing adaptor protein positively regulates BV2 cell M1 polarization. Eur J Neurosci. 2016;43:1674\u201382.","journal-title":"Eur J Neurosci"},{"key":"535_CR87","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.celrep.2012.02.014","volume":"1","author":"T Masuda","year":"2012","unstructured":"Masuda T, Tsuda M, Yoshinaga R, Tozaki-Saitoh H, Ozato K, Tamura T, et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 2012;1:334\u201340.","journal-title":"Cell Rep"},{"key":"535_CR88","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jphs.2015.08.002","volume":"128","author":"T Masuda","year":"2015","unstructured":"Masuda T, Iwamoto S, Mikuriya S, Tozaki-Saitoh H, Tamura T, Tsuda M, et al. Transcription factor IRF1 is responsible for IRF8-mediated IL-1beta expression in reactive microglia. J Pharmacol Sci. 2015;128:216\u201320.","journal-title":"J Pharmacol Sci"},{"key":"535_CR89","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4049\/jimmunol.1701571","volume":"200","author":"H Cui","year":"2018","unstructured":"Cui H, Banerjee S, Guo S, Xie N, Liu G. IFN regulatory factor 2 inhibits expression of glycolytic genes and lipopolysaccharide-induced Proinflammatory responses in macrophages. J Immunol. 2018;200:3218\u201330.","journal-title":"J Immunol"},{"key":"535_CR90","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11302-014-9413-8","volume":"10","author":"T Masuda","year":"2014","unstructured":"Masuda T, Nishimoto N, Tomiyama D, Matsuda T, Tozaki-Saitoh H, Tamura T, et al. IRF8 is a transcriptional determinant for microglial motility. Purinergic Signal. 2014;10:515\u201321.","journal-title":"Purinergic Signal"},{"key":"535_CR91","volume":"13","author":"S Xu","year":"2021","unstructured":"Xu S, Mei S, Lu J, Wu H, Dong X, Shi L, et al. Transcriptome analysis of microglia reveals that the TLR2\/IRF7 signaling Axis mediates Neuroinflammation after subarachnoid hemorrhage. Front Aging Neurosci. 2021;13:645649.","journal-title":"Front Aging Neurosci"},{"key":"535_CR92","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772\u20137.","journal-title":"Nature"},{"key":"535_CR93","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020;130:1912\u201330.","journal-title":"J Clin Invest"},{"key":"535_CR94","unstructured":"Dorman LC, Nguyen PT, Escoubas CC, Vainchtein ID, Xiao Y, Lidsky PV, et al. A type I interferon response defines a conserved microglial state required for effective phagocytosis. bioRxiv. 2021 2021.2004.2029.441889."},{"key":"535_CR95","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1091\/mbc.e06-10-0975","volume":"18","author":"A Majumdar","year":"2007","unstructured":"Majumdar A, Cruz D, Asamoah N, Buxbaum A, Sohar I, Lobel P, et al. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol Biol Cell. 2007;18:1490\u20136.","journal-title":"Mol Biol Cell"},{"key":"535_CR96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-7-93","volume":"7","author":"AW Corona","year":"2010","unstructured":"Corona AW, Huang Y, O'Connor JC, Dantzer R, Kelley KW, Popovich PG, et al. Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation. 2010;7:93.","journal-title":"J Neuroinflammation"},{"key":"535_CR97","doi-asserted-by":"crossref","unstructured":"Kaiser T, Feng G. Tmem119-EGFP and Tmem119-CreERT2 transgenic mice for labeling and manipulating microglia. eNeuro. 2019;6:ENEURO.0448-18.2019.","DOI":"10.1523\/ENEURO.0448-18.2019"},{"key":"535_CR98","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41467-018-02926-5","volume":"9","author":"M Olah","year":"2018","unstructured":"Olah M, Patrick E, Villani AC, Xu J, White CC, Ryan KJ, et al. A transcriptomic atlas of aged human microglia. Nat Commun. 2018;9:539.","journal-title":"Nat Commun"},{"key":"535_CR99","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-020-00377-5","volume":"15","author":"S Rayaprolu","year":"2020","unstructured":"Rayaprolu S, Gao T, Xiao H, Ramesha S, Weinstock LD, Shah J, et al. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease. Mol Neurodegener. 2020;15:28.","journal-title":"Mol Neurodegener"},{"key":"535_CR100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt.4038","volume":"36","author":"BB Lake","year":"2018","unstructured":"Lake BB, Chen S, Sos BC, Fan J, Kaeser GE, Yung YC, et al. Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain. Nat Biotechnol. 2018;36:70\u201380.","journal-title":"Nat Biotechnol"},{"key":"535_CR101","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nn.4597","volume":"20","author":"TF Galatro","year":"2017","unstructured":"Galatro TF, Holtman IR, Lerario AM, Vainchtein ID, Brouwer N, Sola PR, et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat Neurosci. 2017;20:1162\u201371.","journal-title":"Nat Neurosci"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00535-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T15:12:50Z","timestamp":1720710770000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00535-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00535-x","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved and conducted in accordance with IACUC regulations at Emory University and the University of South Florida.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}